Cost and efficacy of immunosuppression using generic products following living donor liver transplantation in India

Indian Journal of Gastroenterology

Volumn 31, Issue 1, 2012, Pages 20-23

  Sudhindran, S ^a   Aboobacker, Shameena ^a   Menon, Ramachanndran N ^a   Unnikrishnan, G ^a   Sudheer, O V ^a   Dhar, Puneet ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cost; Generics; Immunosuppression; India; Living donor liver transplant; Side effects

Indexed keywords

CORTICOSTEROID; GENERIC DRUG; METHYLPREDNISOLONE; MYCEPT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMNACORTIL; PANGRAF; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; HUMAN; HYPERKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; INDIA; KIDNEY DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NEUROTOXICITY; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREMOR;

HEALTH CARE COSTS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INDIA; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 84857914421     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-011-0138-0     Document Type: Article

References (7)

1. Ng KK, Lo CM. Liver transplantation in Asia: past, present and future. Ann Acad Med Singapore. 2009; 38: 322-31.
2. Kakodkar R, Soin A, Nundy S. Liver transplantation in India: its evolution, problems and the way forward. Natl Med J India. 2007; 20: 53-6.
3. Soin AS. Current status of living donor liver transplantation. GI Surgery Annual. 2002; 9: 79-100.
4. McDevitt-Potter LM, Sadaka B, Tichy EM, Rogers CC, Gabardi S. A multicenter experience with generic tacrolimus conversion. Transplantation. 2011; 92: 653-7.
5. Sapna S, Dave C, Rachel J, et al. Long-term graft outcome with mycophenolate mofetil and azathioprine: a paired kidney analysis. Transplantation. 2006; 82: 1634-9.
6. Germani G, Pleguezuelo M, Villamil F, et al. Azathioprine in liver transplantation: a re-evaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant. 2009; 9: 1725-31.
7. Stegall M, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Transplantation. 1995; 60: 1057-60.